Author

M. Monavarian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

K. Mythreye· 3 shared N. Hempel· 3 shared A. K. Shelton· 2 shared C. R. Miller· 2 shared N. Y. Lee· 2 shared R. C. Arend· 2 shared A. Berchuck· 1 shared A. Kumari· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

K. Mythreye

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Anoikis resistance and metastasis of ovarian cancer can be overcome by CDK8/19 Mediator kinase inhibition.

M. Monavarian, R. Rajkarnikar, E. F. Page, A. Kumari, L. Q. Macias, F. Massicano, N. Y. Lee, S. Sahoo, N. Hempel, M. K. Jolly, L. Ianov, E. Worthey, A. Singh, I. Roninson, E. V. Broude, , K. Mythreye

This study shows CDK8/19 inhibition can reverse anoikis resistance and metastasis in ovarian cancer by altering transcriptional programs.

bioRxiv · Dec 4, 2023Cancer Biology

PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistance

K. Tabury, M. Monavarian, E. Listik, A. K. Shelton, A. S. Choi, R. Quintens, R. C. Arend, N. Hempel, C. R. Miller, B. Györrfy, K. Mythreye

This study identifies PVT1, a YAP1-dependent stress-responsive lncRNA that promotes ovarian cancer metastasis and chemoresistance, suggesting it as a therapeutic target.

bioRxiv · Jan 11, 2022 · PreprintCancer Biology

Reciprocal epigenetic Sox2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer

Z. SHONIBARE, M. Monavarian, K. O'Connell, D. Altomare, A. K. Shelton, S. Mehta, R. Jaskula-Sztul, R. Phaeton, M. D. Starr, R. Whitaker, A. Berchuck, A. Nixon, R. C. Arend, N. Y. Lee, C. R. Miller, , K. Mythreye

This study identifies Sox2 as a key node regulated by opposing TGF-β superfamily signals, impacting anoikis resistance and metastasis in ovarian cancer.

bioRxiv · Jan 11, 2022Cancer Biology

Decellularized Articular Cartilage Microparticles for Expansion of Mesenchymal Stem Cells and Zonal Regeneration of Articular Cartilage

A. Sepahvandi, S. I. Kader, V. A. Madormo, M. Monavarian, E. Jabbari

This paper develops a method to regenerate articular cartilage using decellularized microparticles to expand and fuse mesenchymal stem cells into multilayer constructs.

bioRxiv · Apr 16, 2021Bioengineering